These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 18058328)

  • 1. Interaction between valproic acid and carbapenem antibiotics.
    Mori H; Takahashi K; Mizutani T
    Drug Metab Rev; 2007; 39(4):647-57. PubMed ID: 18058328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased valproate level caused by VPA-glucuronidase inhibition by carbapenem antibiotics.
    Nakamura Y; Nakahira K; Mizutani T
    Drug Metab Lett; 2008 Dec; 2(4):280-5. PubMed ID: 19356106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of carbapenem antibiotics on plasma concentrations of valproic acid.
    Mancl EE; Gidal BE
    Ann Pharmacother; 2009 Dec; 43(12):2082-7. PubMed ID: 19934386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Panipenum, a carbapenem antibiotic, increases the level of hepatic UDP-glucuronic acid in rats.
    Yamamura N; Imura-Miyoshi K; Naganuma H
    Drug Metab Dispos; 2000 Dec; 28(12):1484-6. PubMed ID: 11095587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased erythrocyte distribution of valproic acid in pharmacokinetic interaction with carbapenem antibiotics in rat and human.
    Omoda K; Murakami T; Yumoto R; Nagai J; Maeda Y; Kiribayashi Y; Takano M
    J Pharm Sci; 2005 Aug; 94(8):1685-93. PubMed ID: 15986463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo inhibition of acylpeptide hydrolase by carbapenem antibiotics causes the decrease of plasma concentration of valproic acid in dogs.
    Suzuki E; Nakai D; Ikenaga H; Fusegawa K; Goda R; Kobayashi N; Kuga H; Izumi T
    Xenobiotica; 2016; 46(2):126-31. PubMed ID: 26075835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of the drug interaction between valproic acid and carbapenem antibiotics in monkeys and rats.
    Nakajima Y; Mizobuchi M; Nakamura M; Takagi H; Inagaki H; Kominami G; Koike M; Yamaguchi T
    Drug Metab Dispos; 2004 Dec; 32(12):1383-91. PubMed ID: 15345660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Seven cases of decreased serum valproic acid concentration during concomitant use of carbapenem antibiotics].
    Lee SG; Kim JH; Joo JY; Kwon OH
    Korean J Lab Med; 2007 Oct; 27(5):338-43. PubMed ID: 18094598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Panipenem, a carbapenem antibiotic, enhances the glucuronidation of intravenously administered valproic acid in rats.
    Yamamura N; Imura K; Naganuma H; Nishimura K
    Drug Metab Dispos; 1999 Jun; 27(6):724-30. PubMed ID: 10348803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Observation of Clinically Relevant Drug Interaction in Chimeric Mice with Humanized Livers: The Case of Valproic Acid and Carbapenem Antibiotics.
    Suzuki E; Koyama K; Nakai D; Goda R; Kuga H; Chiba K
    Eur J Drug Metab Pharmacokinet; 2017 Dec; 42(6):965-972. PubMed ID: 28447323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of inhibitory effect of carbapenem antibiotics on the deconjugation of valproic acid glucuronide.
    Masuo Y; Ito K; Yamamoto T; Hisaka A; Honma M; Suzuki H
    Drug Metab Dispos; 2010 Oct; 38(10):1828-35. PubMed ID: 20581094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced valproic acid serum concentrations due to drug interactions with carbapenem antibiotics: overview of 6 cases.
    Park MK; Lim KS; Kim TE; Han HK; Yi SJ; Shin KH; Cho JY; Shin SG; Jang IJ; Yu KS
    Ther Drug Monit; 2012 Oct; 34(5):599-603. PubMed ID: 22929406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First case report of suspected onset of convulsive seizures due to co-administration of valproic acid and tebipenem.
    Shihyakugari A; Miki A; Nakamoto N; Satoh H; Sawada Y
    Int J Clin Pharmacol Ther; 2015 Jan; 53(1):92-6. PubMed ID: 25407257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Effect of Different Carbapenem Antibiotics (Ertapenem, Imipenem/Cilastatin, and Meropenem) on Serum Valproic Acid Concentrations.
    Wu CC; Pai TY; Hsiao FY; Shen LJ; Wu FL
    Ther Drug Monit; 2016 Oct; 38(5):587-92. PubMed ID: 27322166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of valproic acid glucuronide hydrolase as a key enzyme for the interaction of valproic acid with carbapenem antibiotics.
    Suzuki E; Yamamura N; Ogura Y; Nakai D; Kubota K; Kobayashi N; Miura S; Okazaki O
    Drug Metab Dispos; 2010 Sep; 38(9):1538-44. PubMed ID: 20551238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Valproic acid-carbapenem interaction: report of six cases and a review of the literature.
    Tobin JK; Golightly LK; Kick SD; Jones MA
    Drug Metabol Drug Interact; 2009; 24(2-4):153-82. PubMed ID: 20408498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible mechanism by which the carbapenem antibiotic panipenem decreases the concentration of valproic acid in plasma in rats.
    Kojima S; Nadai M; Kitaichi K; Wang L; Nabeshima T; Hasegawa T
    Antimicrob Agents Chemother; 1998 Dec; 42(12):3136-40. PubMed ID: 9835504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition by carbapenem antibiotic imipenem of intestinal absorption of valproic acid in rats.
    Torii M; Takiguchi Y; Saito F; Izumi M; Yokota M
    J Pharm Pharmacol; 2001 Jun; 53(6):823-9. PubMed ID: 11428658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of valproic acid and carbapenem antibiotics with multidrug resistance-associated proteins in rat erythrocyte membranes.
    Ogawa K; Yumoto R; Hamada N; Nagai J; Takano M
    Epilepsy Res; 2006 Sep; 71(1):76-87. PubMed ID: 16806827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbapenem antibiotics inhibit valproic acid transport in Caco-2 cell monolayers.
    Torii M; Takiguchi Y; Izumi M; Fukushima T; Yokota M
    Int J Pharm; 2002 Feb; 233(1-2):253-6. PubMed ID: 11897429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.